CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 11,182 shares (grant or award)
- 4 Grant or award Director acquired 23,762 shares (grant or award)
- 4 Grant or award Director acquired 16,773 shares (grant or award)
- 4 Grant or award Director acquired 15,026 shares (grant or award)
- 4 Open-market buy SVP, Clinical Operations bought 15,000 shares at $3.80 ($56,960)
- 4 Open-market buy Director bought 44,950 shares at $3.15 ($141,593)
- 4 Open-market buy Director bought 15,000 shares at an average $3.27 ($49,064)
- 4 Open-market buy Senior VP, Clinical Operations bought 20,721 shares at an average $3.09 ($64,054)
- 4 Open-market buy President and CEO bought 5,000 shares at $3.14 ($15,700)
- 4 Open-market buy CFO and Secretary bought 10,000 shares at $3.15 ($31,463)
- 4 Derivatives Options or other derivatives
Page 6 of 9 · 176 filings